Jazz Pharmaceuticals (JAZZ) Land & Improvements (2014 - 2016)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Land & Improvements of $1.8 million in Q1 2016, up 3.55% quarter-over-quarter from $1.8 million in Q4 2015, and up 33.19% on a YoY basis from $1.4 million in Q2 2015.
Jazz Pharmaceuticals (JAZZ) Land & Improvements (2014 - 2016) Analysis & Trends
Jazz Pharmaceuticals' Land & Improvements history runs 3 years deep, the most recent figure standing at $1.8 million for Q1 2016.
- In Q1 2016, Land & Improvements rose 33.19% year-over-year to $1.8 million; the TTM figure through Mar 2016 stood at $1.8 million (up 33.19% YoY), while the FY2015 annual figure was $1.8 million, up 14.74% from the prior year.
- Land & Improvements was $1.8 million for Q1 2016 at Jazz Pharmaceuticals, up from $1.8 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $1.8 million in Q1 2016 to a low of $1.4 million in Q1 2015.
- Historically, Land & Improvements has averaged $1.7 million across 3 years, with a median of $1.7 million in 2014.
- The sharpest annual moves came in 2015 and 2016: Land & Improvements decreased 17.76% in 2015, then surged 33.19% in 2016.
- A 3-year view of Land & Improvements shows it stood at $1.5 million in 2014, then gained by 14.74% to $1.8 million in 2015, then gained by 3.55% to $1.8 million in 2016.
- The last three Land & Improvements figures came in at $1.8 million (Q1 2016), $1.8 million (Q4 2015), and $1.8 million (Q3 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 1.84 Mn |
| Dec 31, 2015 | 1.78 Mn |
| Sep 30, 2015 | 1.78 Mn |
| Jun 30, 2015 | 1.69 Mn |
| Mar 31, 2015 | 1.38 Mn |
| Dec 31, 2014 | 1.55 Mn |
| Sep 30, 2014 | 1.61 Mn |
| Jun 30, 2014 | 1.69 Mn |
| Mar 31, 2014 | 1.68 Mn |